Bipolar affective disorder in a patient with neurosarcoidosis – A case report

Authors

  • Arun Joy Government Medical College, Thrissur, Kerala
  • T N Nithin Murali Government Medical College, Thrissur, Kerala
  • Anithakumari Ayirolimeethal Government Medical College, Thrissur, Kerala
  • Harish M Tharayil Government Medical College, Thrissur, Kerala

DOI:

https://doi.org/10.30834/KJP.37.1.2024.420

Keywords:

Neurosarcoidosis, bipolar disorder, leptomeningeal enhancement

Abstract

Background: Sarcoidosis is a rare clinical condition that can involve the central nervous system. 20% of cases of neurosarcoidosis (NS) can have psychiatric manifestations. Here, we highlight a case of bipolar affective disorder (BPAD) for 25 years with NS. Case report: A 50-year-old woman presented with progressive sensorineural hearing loss from 15 years of age and BPAD for 25 years. She developed generalized tonic clonic seizure and catatonia while on sodium valproate, leading to a detailed medical evaluation. Neuroimaging showed leptomeningeal enhancements, atherosclerosis, and stenosis of the internal carotid artery. Her serum angiotensin-converting enzyme level was elevated, and chest X-ray showed parenchymal lesions. She was diagnosed with neurosarcoidosis. Her condition improved with steroids and mycophenolate mofetil. BPAD was treated with sodium valproate. Discussion: Rare medical conditions like NS can present as psychiatric disorders. Poor response and vulnerability to adverse effects of psychotropics warrant a detailed clinical evaluation for organic etiology.

References

Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Neurol Neuroimmunol Neuroinflam. 2021;8(6):e1084. Available from: DOI: 10.1212/NXI.0000000000001084.

Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J 2016;48:1690-9.

Burns TM. Neurosarcoidosis. Arch Neurol 2003;60:1166-8.

Lacomis D. Neurosarcoidosis. Curr Neuropharmacol 2011;9:429-36.

Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 2007;64:691-6.

Carlson ML, White Jr JR, Espahbodi M, Haynes DS, Driscoll CLW, Aksamit AJ, et al. Cranial base manifestations of neurosarcoidosis: a review of 305 patients. Otol Neurotol 2015;36:156-66.

Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, et al. Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series. Neurology 2017;89:2092-100.

Stern BJ, Royal 3rd W, Gelfand JM, Clifford DB, Tavee J, Pawate S, et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol 2018;75:1546-53.

McLoughlin D, McKeon P. Bipolar disorder and cerebral sarcoidosis. Br J Psychiatry 1991;158:410-3.

Hoss S, Grinberg T, Eisen A. The interrelationship between sarcoidosis and atherosclerosis—complex yet rational. J Clin Med 2022;11:433. Available from: DOI: 10.3390/jcm11020433.

Shoib S, Das S, Saleem SM, Nagendrappa S, Khan KS, Ullah I. Neurosarcoidosis masquerading as mania with psychotic features—A case report. Ind Psychiatry J 2023;32:187-9.

Downloads

Published

10-04-2024

How to Cite

Joy, A., T. N. N. Murali, A. Ayirolimeethal, and H. M. Tharayil. “Bipolar Affective Disorder in a Patient With Neurosarcoidosis – A Case Report”. Kerala Journal of Psychiatry, vol. 37, no. 1, Apr. 2024, pp. 51-54, doi:10.30834/KJP.37.1.2024.420.

Issue

Section

Case Report